Clare Market Investments’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$349K Sell
13,687
-6,054
-31% -$149K 0.07% 123
2025
Q2
$479K Sell
19,741
-5,421
-22% -$126K 0.11% 98
2025
Q1
$638K Sell
25,162
-16,115
-39% -$422K 0.17% 71
2024
Q4
$1.1M Sell
41,277
-17,038
-29% -$462K 0.26% 49
2024
Q3
$1.69M Buy
58,315
+48,516
+495% +$1.42M 0.44% 34
2024
Q2
$274K Buy
+9,799
New +$270K 0.08% 117
2023
Q1
Sell
-5,350
Closed -$274K 140
2022
Q4
$274K Sell
5,350
-8,076
-60% -$387K 0.13% 92
2022
Q3
$588K Sell
13,426
-1,589
-11% -$77.2K 0.25% 56
2022
Q2
$787K Sell
15,015
-5,020
-25% -$256K 0.34% 37
2022
Q1
$1.04M Buy
20,035
+2,719
+16% +$141K 0.33% 41
2021
Q4
$1.02M Sell
17,316
-788
-4% -$39K 0.29% 48
2021
Q3
$779K Sell
18,104
-13,352
-42% -$592K 0.23% 55
2021
Q2
$1.23M Buy
31,456
+12,057
+62% +$469K 0.4% 36
2021
Q1
$703K Buy
19,399
+7,519
+63% +$267K 0.26% 54
2020
Q4
$437K Buy
11,880
+2,505
+27% +$91.9K 0.18% 67
2020
Q3
$326K Buy
9,375
+1,191
+15% +$41.8K 0.16% 70
2020
Q2
$254K Buy
8,184
+27
+0.3% +$917 0.15% 71
2020
Q1
$253K Sell
8,157
-3,116
-28% -$106K 0.21% 65
2019
Q4
$419K Sell
11,273
-1,040
-8% -$37K 0.3% 58
2019
Q3
$420K Sell
12,313
-2,908
-19% -$106K 0.4% 53
2019
Q2
$626K Buy
15,221
+30
+0.2% +$1.19K 0.5% 49
2019
Q1
$612K Sell
15,191
-341
-2% -$13.7K 0.53% 41
2018
Q4
$643K Buy
+15,532
New +$645K 0.83% 27

Other funds holding PFE

Clare Market Investments's PFE Position: Q3 2025 in Review

Clare Market Investments reduced its Pfizer (PFE) stake by 31% in Q3 2025, selling an estimated $149K and leaving 13,687 shares worth $349K. The position accounts for 0.07% of the portfolio, ranked #123.

Clare Market Investments first reported a position in PFE in Q4 2018 and has held it in 23 quarters since. The position peaked at $1.69M in Q3 2024. 2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

  • Clare Market Investments held 13,687 shares of Pfizer worth $349K as of Q3 2025.
  • Clare Market Investments sold 6,054 Pfizer shares in Q3 2025, an estimated $149K.
  • Pfizer made up 0.07% of Clare Market Investments's portfolio in Q3 2025, its #123 holding.
  • Clare Market Investments first reported a position in Pfizer in Q4 2018 and has held it in 23 quarters since.
  • Clare Market Investments's Pfizer position peaked at $1.69M in Q3 2024.
  • 2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on Clare Market Investments's 13F filing for Q3 2025, filed 12 Nov 2025.